Patents by Inventor Benoit Maurice Mullet

Benoit Maurice Mullet has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7138133
    Abstract: The present invention is an orally administered liquid pharmaceutical composition that demonstrates excellent physical stability while delivering concentrated levels of the pharmaceutical active(s). Specifically, these compositions for extended periods do not allow the active to precipitate or settle out of solution. Among the advantages of this invention is that the compositions do not require agitation/shaking prior to use as a method to re-suspend or dissolve active drug material to insure even and consistent dosing.
    Type: Grant
    Filed: October 10, 2001
    Date of Patent: November 21, 2006
    Assignee: The Procter & Gamble Company
    Inventors: Douglas Joseph Dobrozsi, Jerry William Hayes, II, Francis Joseph David Bealin-Kelly, Jayant Eknath Khanolkar, Benoit Maurice Mullet, Shane Michael DE LA Harpe, Brian James Robbins
  • Publication number: 20040234457
    Abstract: The present invention is directed to methods of preventing and treating Severe Acute Respiratory Syndrome (SARS) by the administration of respiratory tract compositions having low pH values. The respiratory tract compositions have a pH of from about 3.0 to about 5.5, and are preferably administered to areas of the respiratory tract such as the nasal cavity to effectively prevent and treat respiratory tract viral infections, particularly SARS. The respiratory tract compositions comprise an organic acid in combination with a metal compound.
    Type: Application
    Filed: February 2, 2004
    Publication date: November 25, 2004
    Applicant: The Procter & Gamble Company
    Inventors: Paul John Rennie, Shane Michael De La Harpe, Jayant Ekanth Khanolkar, Benoit Maurice Mullet
  • Publication number: 20030113377
    Abstract: The present invention is an orally administered liquid pharmaceutical composition that demonstrates excellent physical stability while delivering concentrated levels of the pharmaceutical active(s). Specifically, these compositions for extended periods do not allow the active to precipitate or settle out of solution.
    Type: Application
    Filed: October 10, 2001
    Publication date: June 19, 2003
    Inventors: Douglas Joseph Dobrozsi, Jerry William Hayes, Francis Joseph David Bealin-Kelly, Jayant Eknath khanolkar, Benoit Maurice Mullet, Shane Michael Dela Harpe, Brian James Robbins